P&S Intelligence Archivi - World Wide Trends

28 marzo 2025

Rising Water Efficiency Needs Drive Smart Irrigation Market

According to the latest market research study published by P&S Intelligence, the global smart irrigation market is experiencing significant growth, with revenues projected to increase from USD 1.8 billion in 2024 to USD 4.4 billion by 2032, reflecting a compound annual growth rate (CAGR) of 12.4%. This expansion is driven by heightened research and development activities and the widespread adoption of energy-efficient smart irrigation systems. Additionally, regions frequently facing extreme weather conditions are increasingly relying on these advanced systems to ensure efficient water management in agriculture.

Key Insights

Segmentation Analysis:

The market encompasses various systems, including weather-based and sensor-based solutions.

Key components comprise controllers, sensors, and water flow meters.

Applications span both agricultural and non-agricultural sectors, with non-agricultural applications currently holding the largest market share.

Regional and Geographical Trends:

North America leads the market in size, attributed to early adoption and technological advancements.

The Asia-Pacific region is the fastest-growing market, driven by increased deployment of remote sensing technologies and integration of IoT devices in countries like India, China, South Korea, and Australia.

Technological Advancements Shaping the Market:

Integration of IoT-enabled systems allows automatic irrigation based on real-time soil moisture levels, enhancing water conservation.

Advanced features incorporating artificial intelligence (AI) and machine learning (ML) facilitate temperature and soil moisture sensing, weather pattern tracking, and long-term environmental forecasting, optimizing water usage and preventing wastage.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is fragmented, featuring a diverse range of applications and technologies, which encourages the entry of niche and personalized product offerings.

Prominent manufacturers include Rain Bird Corporation, The Toro Company, Hunter Industries Inc., Manna Irrigation, Stevens Water Monitoring Systems, Delta-T Devices, HydroPoint, GREEN ELECTRONICS LLC, Valmont Industries Inc., Water Ways Technologies Inc., Orbit Irrigation Products, and Acclima Inc.

Government initiatives promoting sustainable agriculture and water conservation, such as India’s Pradhan Mantri Krishi Sinchayee Yojana (PMKSY), are creating favorable conditions for market expansion.

Overall, the smart irrigation market is poised for robust growth, driven by technological innovations, supportive government policies, and the increasing need for efficient water management solutions across various regions.

19 marzo 2025

Patient Referral Management Software Market Set for 17.9% CAGR Through 2030

According to the latest market research study published by P&S Intelligence, the global patient referral management software market was valued at USD 9,598.3 million in 2023 and is expected to experience robust growth, with a CAGR of 17.9% from 2024 to 2030, reaching USD 30,221.2 million by the end of the forecast period. This growth is primarily driven by an aging global population, increased government initiatives promoting healthcare IT adoption, and continuous technological advancements. The software’s role in streamlining referral processes, enhancing communication among healthcare professionals, and improving patient care quality is also a significant factor supporting its widespread adoption.

Technological innovations, such as cloud-based solutions, electronic prescriptions, and integrated health records, further enhance the efficiency and accuracy of patient referral management. These advancements are poised to address the challenges of referral leakage, patient tracking, and communication barriers, thus contributing to the market’s expansion.

Key Insights

The patient referral management software market is segmented into software and services, with the software category holding the largest share in 2023. It is expected to grow rapidly due to its enhanced accuracy and efficiency in managing healthcare operations.

The inbound referrals segment is projected to witness the fastest growth, with a CAGR of 17.9% from 2024 to 2030, as hospitals increasingly utilize digital platforms to handle the influx of referrals.

Cloud-based solutions are expected to dominate the market, thanks to their cost-efficiency, scalability, and better data security compared to on-premises systems. Healthcare providers are increasingly adopting cloud solutions for their operational flexibility.

The providers category is expected to be the largest and fastest-growing end-user segment, advancing at a CAGR of 18.2%. Healthcare providers benefit from improved coordination, reduced referral leakage, and automated processes, ultimately enhancing operational efficiency.

North America holds the largest market share, with strong growth driven by the region’s advanced healthcare infrastructure, increasing adoption of telehealth, and growing use of artificial intelligence and data analytics in healthcare.

Geriatric care is a significant driver for the market, as the elderly population requires efficient, timely access to specialized healthcare. Referral management software ensures better coordination and care for the aging population.

Technological developments, including the integration of electronic health records and the rise of digital health solutions, are key factors accelerating market growth, optimizing referral processes, and improving overall patient satisfaction.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

27 febbraio 2025

California Tops U.S. Endoscope Repair Market with 15% Share

The U.S. endoscope repair market is poised for significant growth, with projections indicating a rise from USD 533.5 million in 2024 to USD 990.7 million by 2030, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period. This expansion is primarily driven by the increasing adoption of minimally invasive surgical procedures, a higher prevalence of gastrointestinal and colorectal diseases, and the inherent need for regular maintenance due to the delicate nature of endoscope components. Additionally, the aging population and the proliferation of healthcare facilities across the nation further bolster the demand for endoscope repair services.

Key Insights

Dominance of Flexible Endoscopes

In 2024, flexible endoscopes are anticipated to constitute approximately 73% of the market share. Their ability to navigate complex internal pathways, coupled with enhanced patient comfort, underscores their widespread preference in medical procedures.

Service Provider Landscape

Original Equipment Manufacturers (OEMs) are projected to remain the predominant service providers in 2024. However, Independent Service Organizations (ISOs) are expected to experience a higher growth trajectory, with a CAGR of 12.2% during the forecast period. This surge is attributed to their competitive pricing models, offering cost-effective solutions without compromising on service quality.

Regional Highlights

California is set to lead the market, accounting for 15% of the revenue share in 2024, and is projected to witness a CAGR of 12.5% through 2030. The state’s extensive network of healthcare facilities and a diverse patient population contribute to the heightened demand for endoscope repair services.

Technological Advancements

The evolution of endoscopic technologies, such as the transition to ultra-high-definition imaging and the integration of narrow-band imaging (NBI), has enhanced diagnostic precision. These advancements necessitate specialized repair and maintenance services to ensure optimal performance.

Competitive Dynamics

The market is characterized by fragmentation, with numerous players including OEMs, ISOs, and in-house hospital repair departments. This diversity fosters a competitive environment, driving service providers to continually enhance their offerings.

Key Market Players

Prominent companies operating in the U.S. endoscope repair market include Smith & Nephew Inc., The Cooper Companies Inc., Intuitive Surgical Inc., Richard Wolf Medical Instruments Corporation, FUJIFILM Holdings America Corporation, KARL STORZ SE & Co. KG, CONMED Corporation, Arthrex Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Stryker Corporation.

Market Fragmentation

The presence of multiple service providers, ranging from established OEMs to emerging ISOs, contributes to a fragmented market landscape. This fragmentation offers healthcare providers a variety of options, fostering competitive pricing and service quality.

Growth Drivers

The market’s expansion is fueled by a combination of factors, including the increasing preference for minimally invasive procedures, a rising incidence of gastrointestinal ailments, and the continuous advancements in endoscopic technologies. These elements collectively enhance the demand for specialized endoscope repair services.

Future Outlook

With the healthcare sector’s ongoing emphasis on technological innovation and patient-centric care, the U.S. endoscope repair market is poised for sustained growth. Service providers that prioritize quality, affordability, and technological adeptness are likely to secure a competitive edge in this evolving landscape.

In summary, the U.S. endoscope repair market is on a robust growth trajectory, driven by technological advancements, a diverse service provider ecosystem, and an increasing demand for minimally invasive medical procedures. Stakeholders are encouraged to capitalize on emerging opportunities to establish a strong foothold in this dynamic market.

About P&S Intelligence

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

3 febbraio 2025

Global Demand for Digital Identity Solutions Surges Amid Cybersecurity Risks

The global digital identity solutions market is experiencing significant growth, with revenues projected to increase from USD 40.1 billion in 2024 to USD 117.42 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.6% during this period.

This surge is primarily driven by the escalating number of cybercrimes and fraudulent activities, particularly in the banking, financial services, and insurance (BFSI) and healthcare sectors. Technological advancements, such as the integration of artificial intelligence (AI), machine learning (ML), and blockchain, are enhancing the authentication capabilities of digital identity solutions, further propelling market expansion.

Key Insights

Segmentation Analysis:

Solution Types: The market offers a range of solutions, including identity verification, authentication, single-factor authentication, and multi-factor authentication. These solutions cater to diverse organizational needs, ensuring secure and efficient identity management.
Identity Types: Digital identity solutions encompass both biometric and non-biometric systems. Biometric solutions, utilizing fingerprints, iris scans, and facial recognition, provide heightened security, while non-biometric solutions offer alternative methods for identity verification.

Regional and Geographical Trends:

North America: Currently the largest market, North America’s dominance is attributed to the early adoption of advanced technologies and stringent regulatory frameworks aimed at combating identity fraud.
Asia-Pacific: Anticipated to be the fastest-growing region, the Asia-Pacific market is driven by rapid digitalization, increasing internet penetration, and rising awareness of identity security measures.

Technological Advancements Shaping the Market:

AI and ML Integration: The incorporation of AI and ML algorithms enhances the accuracy and efficiency of identity verification processes, enabling real-time detection of fraudulent activities.
Blockchain Technology: Blockchain offers a decentralized and tamper-proof method for storing digital identities, ensuring data integrity and reducing the risk of unauthorized access.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is characterized by a fragmented landscape with numerous players striving for market share. Key companies are focusing on strategic partnerships, mergers, and acquisitions to enhance their offerings and expand their global presence.
Emerging opportunities lie in the development of identity wallets and the increasing demand for single sign-on (SSO) solutions, which streamline user access across multiple platforms while maintaining robust security protocols.

As organizations and governments worldwide recognize the critical importance of secure digital identity management, the digital identity solutions market is poised for substantial growth, driven by continuous technological innovations and the escalating need to combat cyber threats.

8 novembre 2024

AI in Agriculture: Market Dynamics, Growth Projections, and Regional Performance Through 2030

The AI in agriculture market, valued at USD 1,643.7 million in 2023, is expected to surge to USD 7,854.1 million by 2030, growing at a CAGR of 25.1%. The adoption of IoT and cloud computing is a key driver of AI demand in agriculture, enabling farmers to manage large amounts of data for better decision-making. IoT sensors are widely used for monitoring factors like crop yields, rainfall, pest levels, and soil nutrition, helping farmers optimize productivity.

The need for advanced agricultural technology is growing worldwide, driven by population increases and the need to improve crop yields. Robotics is also playing a bigger role in agriculture, allowing for more sophisticated and sustainable farming methods. Robotics companies are developing AI-equipped products for dynamic farm environments, helping stakeholders increase output while reducing carbon footprints.

Market Insights North America dominated the AI in agriculture market in 2023, capturing 45% of the market due to strong adoption of advanced technologies for productivity gains. The U.S. is projected to grow at a CAGR of over 25.5% this decade, while APAC is expected to grow the fastest, at 25.9%, due to increased adoption of precision farming, agronomic robots, and drone analytics.

The service sector is projected to grow at a CAGR of 25.3%, driven by demand for managed services that help farmers monitor sensor activities and manage crop health data. Machine learning (ML) led the industry in 2023 with nearly 50% market share, thanks to its widespread adoption in crop and field management. Precision farming held a 40% share in 2023, supported by demand for optimized yield and reduced production costs. Drone analytics is expected to grow the fastest, at over 25.7%, driven by increased investment in drone technology to support quality food production for a rising population.

The AI in agriculture market is highly competitive, with numerous international players vying for market share.

30 gennaio 2024

Enhancing Quality and Safety in Biopharmaceutical Manufacturing with Bioprocess Validation

Maintaining high-quality standards is crucial throughout the bioproduct manufacturing process. This involves eliminating contaminants and impurities from chromatographic media, which can consist of viruses, nucleic acids, endotoxins, cell membranes, aggregates, culture media components, proteins, ligands, product alterations, process chemicals, and inactive microbes.

To ensure the effectiveness of equipment and methods used in manufacturing processes, rigorous scientific validation exercises with thorough documentation are necessary. The FDA’s General Principles of Process Validation guidelines require documented evidence at all stages of bioprocess validation studies to provide a high level of confidence in the intended product quality for consumers.

Bioprocess validation is an integrated process that adheres to FDA, EMA, and other national and international regulations and standards. It aims to verify procedures and ensure compliance with current Good Manufacturing Practices (cGMP). Extensive documentation is required by national and international guidelines to confirm that the process follows standard procedures.

To improve production many drug manufacturers are turning to third-party service providers. The use of disposable technologies during medication development further reduces production costs. Single-use bioreactors have increased process adaptability and significantly reduced the risk of cross-contamination. These advancements benefit the bioprocess validation sector by shortening commercialization timelines and ensuring product reliability.

The COVID-19 pandemic has also had a significant impact on bioprocess validation. The demand for validation services increased during the pandemic as validation became necessary at all stages of drug development to monitor accuracy, safety, and efficiency. Extensive testing and manufacturing of vaccines drove the need for process validation.

Increasing Focus on Extractables/Leachables Testing Services

Bioprocess validation services include extractables/leachables testing, bioprocess residual testing, viral clearance testing, and filtration and fermentation systems testing. Extractables/leachables testing dominates this service segment due to the rising risk of product adulteration and the presence of regulatory guidelines. Prominent guidelines in this area include those from the FDA and current good manufacturing practice guidelines.

Rising Utilization of Filter Elements

Bioprocess validation products encompass filter elements, media containers and bags, freezing and thawing process bags, mixing systems, and bioreactor transfer systems. The usage of filter elements is expected to significantly increase, primarily driven by their essential role in various bioprocessing techniques to ensure the efficacy and safety of biopharmaceutical products at each production step.

The use of bioreactors for manufacturing vaccines, medicines, and other pharmaceutical components is also on the rise. Bioreactors are widely employed in healthcare research for converting in-vitro 2D culture models and suspensions into the 3D form, replicating the natural physiological state at the site.

Growing Importance of Biopharmaceuticals

The increasing prevalence of chronic diseases is driving the demand for biopharmaceuticals, leading to the rapid adoption of bioprocess validation services across the healthcare sector. Infectious diseases, cancer, and neurological disorders are becoming more prevalent, highlighting the significance of biopharmaceuticals.

Many biopharmaceuticals used to treat neurodegenerative disorders are directly administered into the brain, which is not feasible with conventional synthetic agents. Furthermore, advancements in bio-based drugs have resulted in higher survival rates for cancer patients, hepatitis cures, improved arthritis management, and transformed treatment options for various diseases. The rising incidence of such diseases drives the growth in biopharmaceutical use, thereby boosting the development of the bioprocess validation sector.

The bioprocess validation sector in Asia is advancing significantly due to increased government support for pharmaceutical research and development, a growing elderly population, and a rising trend of outsourcing in the region. Moreover, the global bioprocess validation industry is projected to reach a value of USD 835 million by the end of this decade.

28 novembre 2023

Biologics CDMO Secondary Packaging Industry Will Grow Fastest in Asia-Pacific

The biologics CDMO secondary packaging market will touch USD 3,622.6 million by 2030, powering at a rate of 8.7% by the end of this decade. This growth is credited to the snowballing drug production, the increasing pharma industry, and the growing prevalence of numerous diseases, such as chronic ailments, infectious ailments, and genetic diseases.

Boxes were the largest category in the industry, with about USD 1 billion revenue, in 2021, and they will continue dominations in the years as well.

Boxes are designed explicitly for the transport of biological products, such as frozen and controlled ambient biologics. They also provide the perfect balance between temperature control and payloads.

North America had the largest revenue share, more than 40%, in the biologics CDMO secondary packaging market. This is because of the increasing outsourcing of drug research and development and production activities by major biopharma players.

Numerous companies wish to team up with competent packing providers providing non-conventional packing solutions and have the vital capabilities to formulate exclusive packing designs in a time and cost-effective manner.

Instead, the APAC will have the fastest growth in the years to come. This growth has a lot to do with the increasing prevalence of chronic ailments, the growing emphasis of businesses on contract manufacturing, and key players are keenly interested in facility developments in the Asia Pacific region.

Furthermore, the growth of the European region will be moderate in nature in the years to come. This can be mainly as a result of the increasing requirement for biologic products, for instance vaccines, driving the research and development spending of the pharma companies.

Due to the increased production of drugs all over the world, the demand for biologics CDMO secondary packaging is on the rise, and this trend will continue in the years to come as well.

24 novembre 2023

Here are 7 Superfoods for Optimal Skin Health

When it comes to achieving glowing and radiant skin, people often rely on expensive skincare products and beauty treatments. However, what many people tend to overlook is the significant impact of their diet on skin health.

The saying “you are what you eat” holds for our skin as well. Consuming a balanced diet that includes skin health foods can work wonders for maintaining a clear, youthful, and vibrant complexion.

Let’s explore seven superfoods that can contribute to optimal skin health, providing essential nutrients and promoting a natural, healthy glow.

Avocado

Known for its high content of healthy fats, avocados are a powerhouse of skin-friendly nutrients. They are packed with monounsaturated fats that help keep the skin moisturized and flexible, reducing the appearance of fine lines and wrinkles.

Additionally, avocados contain vitamins E and C, which act as potent antioxidants, protecting the skin from oxidative damage caused by free radicals.

Sweet Potatoes

Rich in beta-carotene, sweet potatoes are a skin-friendly food that can give your skin a healthy glow. Beta-carotene is converted to vitamin A in the body, which is essential for skin cell turnover and repair. Regular consumption of sweet potatoes can help prevent dry, flaky skin and promote a smoother texture.

Green Tea

Green tea is not only a soothing beverage but also a potent skin health booster. It contains catechins, which have anti-inflammatory and antioxidant properties that can help reduce redness and inflammation. Additionally, green tea can help protect the skin from damage caused by sun exposure and pollution.

Greek Yogurt

Greek yogurt is a great source of probiotics, which play a vital role in promoting a healthy gut. A balanced gut microbiome can positively impact skin health by reducing inflammation and preventing skin conditions like acne and eczema.

Dark Chocolate

Indulging in moderate amounts of dark chocolate (with high cocoa content) can be beneficial for your skin. Dark chocolate is rich in flavonoids, which can enhance blood flow to the skin, improve hydration, and protect against sun damage. Additionally, the antioxidants in dark chocolate can help combat free radicals, promoting a more youthful appearance.

Nuts and Seeds

Almonds, walnuts, chia seeds, and flaxseeds are excellent sources of healthy fats, antioxidants, and vitamins that benefit the skin. Vitamin E in nuts and seeds helps protect the skin from UV damage, while their omega-3 fatty acids maintain skin elasticity and hydration.

Salmon

Salmon is an excellent source of omega-3 fatty acids, which are essential for maintaining skin health. These healthy fats help to keep the skin hydrated and reduce inflammation, promoting a clear and radiant complexion. Omega-3s also support the skin’s natural barrier, which protects against environmental pollutants and irritants.

Additionally, the consumption of fatty fish and walnuts is very high due to the high presence of fatty acids, these acids have numerous benefits, which is why they are now being increasingly utilized in the skincare and beauty industry.

Moreover, these skin health foods are consumed by both adults and elderly people, however, because of the larger population of adults than that of elderly people around the world, these foods are mostly consumed by adults.

Incorporating these skin-boosting foods into your diet, along with a good skincare routine, proper hydration, and sufficient sleep, can contribute to achieving radiant, beautiful skin that glows from within.

Moreover, with the surging R&D spending by a large number of local and foreign businesses producing functional foods and the rising knowledge of the health benefits of functional foods across Asian countries, the need for skin health foods is increasing, and it will reach a value of USD 3,438.9 million by the end of this decade.

2 novembre 2023

3D Bioprinting – Industry Development and Forecast Report 2030

The 3D bioprinting market will power at a rate of 19.4% in the future, to reach USD 5,873 million by 2030. Living organs can be printed in 3D by layering living cells, which is the reason why bio engineering is progressively significant to human society.

With the growing requirement for bio-engineered organs, investigators have made key progressions in this tech.

Hence, the expansion of 3D biomaterials and bioprinters, their use in the pharma and cosmetics industries, and the surge in private and public financing for bioprinting research actions are persuading the industry positively.

Doctors make use of additive manufacturing for the creation of new bones and organs, and it is a major innovation in healthcare. Also, this allows the printing of prosthetic limbs for replacing missing limbs.

Additionally, as compared to the traditional process, which needs a long time and a donor, 3D bioprinting allows the transplantation to be done at a much faster pace.

The requirement for indispensable body parts for transplantation is enormously high globally. For making the things worse, there is an enormous gap amid the supply and requirement of tissues and organs. Numerous organs, for example the kidneys, lungs, heart, pancreas, liver, and intestines, are desired for transplantation.

Likewise, the requirement for heart valves, corneas, skin, blood vessels, and bones for transplantation is somewhat high. Rates of organ donation are still, while the requirement for tissues and organs is growing.

The inaccessibility of such parts for transplantation has brought about an increase in count of patients on the transplantation waiting list, a main anxiety for healthcare organization and providers.

Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample

North America held about 40% share in the recent past, because of the tech-progressions, growing R&D activities and improving healthcare infra. Other than that, the increasing expenditure on healthcare, growing elderly population, and growing prevalence of chronic ailments, is powering the requirement for this tech, particularly in the pharma sector.

APAC 3D bioprinting market will grow the fastest, chiefly due to the fact that its large base of consumers, increasing R&D in this field, and support of the government and tax breaks.

Researchers from China have brought about major progressions in this tech, for instance the liquid-inliquid printing process, in which liquid polymers are combined for forming a steady membrane.

They state that the subsequent liquid developments can hold their shape for about 240 hours, before the combining commences. They printed numerous difficult shapes with the use of this novel method, which has also opened the way for tissue printing from living cells.

The high requirement for tissues and organ transplants all over the world has a lot to do with the increasing demand for 3D bioprinting process.

28 luglio 2023

Benign Prostatic Hyperplasia Treatment Industry Growth and Forecast Report 2023-2030

The benign prostatic hyperplasia treatment market will reach USD 18,837.7 million in 2030, with a CAGR of 5.2% in the years to come. The increasing occurrence of BPH, surging preference for minimally invasive surgeries, and growing investments, funds, and grants for conducting research on novel treatments are the protruding contributors to the development.

The larger share, around 85%, was held by drugs. This is because of the growing requirement for alpha-blockers as these medicines relax the muscle of the prostate and bladder neck, enabling urine flowing more easily.

Amongst the diverse types of drugs, alpha-blockers have been extensively used for treating the disease recently. Their increasing usage and the abundance of medicines under expansion present potential prospects for the industry.

Home healthcare settings had the larger share, and they will record the higher rate, over 5%, in the years to come, as a result of the growing patient count prescribed drugs over surgical treatment.

North America dominated the BPH treatment market with 41% share, as stated by a market research firm, P&S Intelligence. The increasing occurrence of the problem is powering the acceptance of cutting-edge treatments, for example, prostatic stenting, laser therapy, and UroLift therapy, thereby powering the development of the industry in the region.

APAC will grow the fastest in the years to come, at a rate of 6.4%. The improving standards of living, increasing per capita income and spending ability, snowballing burden of urological disease, and increasing investment in the healthcare for boosting the progress.

Furthermore, the increasing aging male population, together with a boom in the occurrence of obesity and diabetes, will power the prevalence of BPH and other lower urinary tract conditions.

China, India and Japan together have a large aging male population, requiring regular medical assistance, being extremely susceptible to chronic ailments as a result of its low immunity.

Therefore, patients with an irregular growth of the prostate are needed to be treated, to prevent urethra blockage and decrease the related cancer risk.

The increasing elderly male population is the main reason for the growing demand for BPH treatment all over the world.